#ECFS2018 – Orkambi Taken for 1 Year Returned Glucose Levels to Normal in Group of CF Patients in Study Jun 11, 2018 07:30 am | Patricia Inacio, PhD

One year of treatment with Orkambi (lumacaftor/ivacaftor) returned blood glucose (sugar) levels to normal in almost half of a small group of diabetic or glucose-intolerant cystic fibrosis (CF) patients with the F508del mutation in the CFTR gene, a study shows. One year of treatment with Orkambi (lumacaftor/ivacaftor) returned blood glucose (sugar) levels to normal in almost half of a small group […] The post #ECFS2018 – Orkambi Taken for 1 Year Returned Glucose Levels to Normal in Group of CF Patients in Study appeared first on Cystic Fibrosis News Today.

Read More

#ECFS2018 – Orkambi Taken for 1 Year Returned Glucose Levels to Normal in Group of CF Patients in Study

JUNE 11, 2018

BY PATRICIA INACIO, PHD

 

IN CYSTIC FIBROSIS, NEWS.